The extension, released shortly before the flexibilities were set to expire at the end of 2025, gives regulators more time to ...

DEA extends telemedicine prescribing flexibilities through 2026, allowing remote controlled substance prescriptions without in-person visits.

The Drug Enforcement Administration (DEA) published a yearlong extension of telemedicine prescribing flexibilities for ...

The American Telemedicine Association announced that the U.S. Drug Enforcement Administration, or DEA, granted a 1-year ...

As providers are becoming more comfortable with delivering care via telemedicine technologies, many of them are looking to explore services other than low acuity triage consults. One area of patient ...

(The Hill) – National pharmaceutical retailer Walgreens has agreed to pay at least $300 million to settle allegations it illegally fulfilled millions of invalid controlled substance prescriptions for ...

The Department of Justice has filed a lawsuit against Walgreens Boots Alliance and its subsidiaries for allegedly dispensing millions of unlawful prescriptions in violation of the Controlled ...